These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 19567522

  • 1. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.
    Bryan SM, Honour JW, Hindmarsh PC.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3477-80. PubMed ID: 19567522
    [Abstract] [Full Text] [Related]

  • 2. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT, Ross RJ.
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [Abstract] [Full Text] [Related]

  • 3. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
    Sarafoglou K, Zimmerman CL, Gonzalez-Bolanos MT, Willis BA, Brundage R.
    J Investig Med; 2015 Jan; 63(1):35-41. PubMed ID: 25386671
    [Abstract] [Full Text] [Related]

  • 4. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
    Melin J, Parra-Guillen ZP, Michelet R, Truong T, Huisinga W, Hartung N, Hindmarsh P, Kloft C.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):. PubMed ID: 32052005
    [Abstract] [Full Text] [Related]

  • 6. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
    Nella AA, Mallappa A, Perritt AF, Gounden V, Kumar P, Sinaii N, Daley LA, Ling A, Liu CY, Soldin SJ, Merke DP.
    J Clin Endocrinol Metab; 2016 Dec 01; 101(12):4690-4698. PubMed ID: 27680873
    [Abstract] [Full Text] [Related]

  • 7. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Charmandari E, Johnston A, Brook CG, Hindmarsh PC.
    J Endocrinol; 2001 Apr 01; 169(1):65-70. PubMed ID: 11250647
    [Abstract] [Full Text] [Related]

  • 8. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.
    Charmandari E, Hindmarsh PC, Johnston A, Brook CG.
    J Clin Endocrinol Metab; 2001 Jun 01; 86(6):2701-8. PubMed ID: 11397874
    [Abstract] [Full Text] [Related]

  • 9. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Gröschl M, Rauh M, Dörr HG.
    J Clin Endocrinol Metab; 2002 Mar 01; 87(3):1200-4. PubMed ID: 11889188
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP.
    J Clin Endocrinol Metab; 2002 Jul 01; 87(7):3197-200. PubMed ID: 12107224
    [Abstract] [Full Text] [Related]

  • 12. The child with difficult to control Congenital Adrenal Hyperplasia: is there a place for continuous subcutaneous hydrocortisone therapy.
    Hindmarsh PC.
    Clin Endocrinol (Oxf); 2014 Jul 01; 81(1):15-8. PubMed ID: 24655023
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ, Wellen JJ, Rijken JC, Stoelinga GB, Benraad TJ.
    J Clin Endocrinol Metab; 1983 Dec 01; 57(6):1150-4. PubMed ID: 6605355
    [Abstract] [Full Text] [Related]

  • 18. Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.
    Hampl R, Foretová L, Sulcová J, Stárka L.
    Eur J Pediatr; 1990 Jan 01; 149(4):232-4. PubMed ID: 2303071
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.